

LAZORIN® is a decongestant that relieves nasal congestion in acute and allergic rhinitis.
The drug begins to act after 5 minutes, the effect lasts up to 8-10 hours. Narrows the vessels of the nasal mucosa, relieves swelling, improves nasal breathing.
To relieve nasal congestion associated with acute rhinitis, vasomotor rhinitis and allergic rhinitis.
To facilitate secretion in sinusitis and otitis media associated with acute rhinitis.
Hypersensitivity to tramazoline hydrochloride or to any of the auxiliary components of the drug.
Glaucoma.
Dry rhinitis.
Contraindicated in patients who have undergone transnasal intracranial surgery.
Inject 1 dose into each nostril up to 3 times a day if necessary. Dosage is determined depending on individual sensitivity and clinical response.
Lazorin® should be used for short-term treatment of acute symptoms for no more than 5-7 days.
In all other cases, according to the indications and for all indications for use, children need an assessment by the doctor of the benefit / risk ratio.
A break of several days should be taken between the individual treatment periods.
Use in children over 6 years old.
During preclinical studies, no evidence was found of any harmful effect of the drug on the embryo.
Do not use LAZORIN® in the first trimester of pregnancy.
In the II and III trimesters of pregnancy and during lactation, the drug should be used only as directed by a doctor.
Active ingredient: tramazolin; 1 ml of the solution contains 1.265 mg of tramazoline hydrochloride monohydrate, which corresponds to 1.18 mg of tramazoline hydrochloride.
Excipients: citric acid monohydrate, sodium hydroxide, benzalkonium chloride, hydroxypropyl methylcellulose, povidone, glycerin (85%), magnesium sulfate heptahydrate, magnesium chloride hexahydrate, calcium chloride dihydrate, sodium hydrogen carbonate, sodium chloride, eucalyptol, menthol, purified, camphor.
Store at a temperature not exceeding 25 ° C in a place inaccessible to children.